PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company, announced that the Company will participate in four upcoming investor conferences in September:
- 2023 Wells Fargo Healthcare Conference: Members of management will be available for one-on-one meetings on Wednesday, September 6, 2023, in Boston, MA.
- Citi’s 18th Annual BioPharma Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a panel discussion titled “Cell Therapies in Autoimmune” on Thursday, September 7, 2023 at 1:50 p.m. ET in Boston, MA. Members of management will also be available for one-on-one meetings.
- H.C. Wainwright 25th Annual Global Investment Conference: Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, September 13, 2023, at 8:30 a.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.
- Morgan Stanley 21st Annual Global Healthcare Conference: Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, September 13, 2023, at 2:15 p.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.
A live webcast of the presentations will be available on the News and Events section of the Company’s website at www.cabalettabio.com. Replays will be available on the website for 30 days.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.